1. Health
Send to a Friend via Email

Discuss in my forum

Barbara Bradley Bolen, Ph.D.

LX1033 on the Fast Track

By January 5, 2013

Follow me on:

Slowly but surely, progress is being made in terms of getting improved IBS medicines to market. Lexicon Pharmaceuticals have announced that the FDA has granted "Fast Track" status to their potential IBS-D drug, LX1033. This status helps to move the FDA approval process along more quickly. LX1033 is an oral medication, designed to act locally in the GI tract. The medication is currently undergoing a Phase II clinical trial.

More on LX1033 from Dr. Bolen, Your IBS Guide


"Lexicon's Drug Candidate for Irritable Bowel Syndrome Receives Fast Track Status from the FDA" Lexicon Pharmaceuticals Website December 17, 2012

Facebook | Twitter | Google+ | Newsletter Signup | Forum

No comments yet. Leave a Comment
Leave a Comment

Line and paragraph breaks are automatic. Some HTML allowed: <a href="" title="">, <b>, <i>, <strike>
Top Related Searches
  • bado
  • fast track
    1. About.com
    2. Health
    3. Irritable Bowel Syndrome

    ©2014 About.com. All rights reserved.

    We comply with the HONcode standard
    for trustworthy health
    information: verify here.